Jon here. Boston is the biotech king, so it was a matter of some concern when the industry hit a slow patch. Good news: the ...

We report a case of a giant parasagittal meningioma discovered incidentally at autopsy in a 36-year-old woman who died ...

Google parent company Alphabet Inc. posted stronger-than-expected results for its second quarter, a sign that it’s massive ...

Rare ‘Dalmatian Doodles’ Have the Coolest Polka-Dot Coats View post: 10-Year-Old Yellow Lab Who's 'Never Known Life in a Home ...

We should start with the number of left fielders. There are 19 here. More designated hitters are classified as left fielders ...

These birds needed this so badly.

Dr. Javin Oza said building synthetic cells in a lab environment is “kind of like rebuilding a car from its parts.” ...

Cells are like metropolises, home to millions of molecular residents. If one were to stand atop a high-rise, trying to ...

SPCX erased all post-IPO gains, falling 30% back to its $135 offering price, while Gesuale's $800 target implies 491% upside. RKLB and ASTS each dropped between 24% and 30% in the same sector selloff, ...

From the column: "Federal budget changes in 2025 that made state reporting of cyclospora cases optional have also made the ...

Shares of SpaceX (NASDAQ:SPCX) are down 5% to $138.58 in early Monday trading, a fresh record low that sits below the $150 ...